The Discovery of Asunaprevir (BMS-650032), An Orally Efficacious NS3 Protease Inhibitor for the Treatment of Hepatitis C Virus InfectionPaul M. Scola, Jialong Zhu, Piyasena Hewawasam et al.|Journal of Medicinal Chemistry|2014Cited by 112
Discovery and Early Clinical Evaluation of BMS-605339, a Potent and Orally Efficacious Tripeptidic Acylsulfonamide NS3 Protease Inhibitor for the Treatment of Hepatitis C Virus InfectionPaul M. Scola, Fiona McPhee, Alan Xiangdong Wang et al.|Journal of Medicinal Chemistry|2014Cited by 69
Analysis and optimization of structure-based virtual screening protocolsRyan Smith, Andrew C. Good, Roderick E. Hubbard et al.|Journal of Molecular Graphics and Modelling|2003Cited by 29
HCV NS5A replication complex inhibitors. Part 3 : discovery of potent analogs with distinct core topologiesOmar D. Lopez, Lawrence B. Snyder, Van N. Nguyen et al.|Bioorganic & Medicinal Chemistry Letters|2012Cited by 29
An efficient one-pot synthesis of 3-glyoxylic acids of electron-deficient substituted azaindoles by ionic liquid imidazolium chloroaluminate-promoted Friedel–Crafts acylationKap‐Sun Yeung, John F. Kadow, Zhilei Qiu et al.|Tetrahedron Letters|2008Cited by 28